Shandong Pharmaceutical Glass CoSHSE:600529 -1.86%83 EBITDA Margin % is 19.68% as of Mar. 2026, which is 18% below its 10-year median of 23.91. GuruFocus rates SHSE:600529 with a GF Score™ of 83/100 and a GF Value™ of ¥23.98 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 390 Packaging & Containers companies, Shandong Pharmaceutical Glass Co ranks better than 86.67% on this metric.
Shandong Pharmaceutical Glass Co (SHSE:600529) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shandong Pharmaceutical Glass Co EBITDA Margin % Related Terms
Shandong Pharmaceutical Glass Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co EBITDA Margin % Chart
SHSE:600529 vs SW, PKG, IP: EBITDA Margin % Comparison
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co EBITDA Margin % vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a EBITDA Margin % of 19.68% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shandong Pharmaceutical Glass Co and its competitors. This is 18% below median its historical median of 23.91. Over the past decade, Shandong Pharmaceutical Glass Co's EBITDA Margin % has ranged from 17.79 to 30.50. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #52 out of 390 companies in the Packaging & Containers industry, placing it in the top 13.3%.
Is Shandong Pharmaceutical Glass Co's EBITDA Margin % too high?
Shandong Pharmaceutical Glass Co's current EBITDA Margin % of 19.68% is 18% below median its 10-year median of 23.91. Over the past 10 years, this metric has ranged from a low of 17.79 to a high of 30.50. The Packaging & Containers industry median EBITDA Margin % is 9.60. Shandong Pharmaceutical Glass Co's value of 19.68% is 105.1% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #52 out of 390 companies in the Packaging & Containers industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's EBITDA Margin % compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #52 out of 390 companies for EBITDA Margin %. This places Shandong Pharmaceutical Glass Co in the top 13% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.60. Shandong Pharmaceutical Glass Co's value of 19.68% is 105.1% above this benchmark. Historically, Shandong Pharmaceutical Glass Co's own EBITDA Margin % has ranged from 17.79 to 30.50 over the past decade. While the company's 10-year median is 23.91 vs. the industry median of 9.60, Shandong Pharmaceutical Glass Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Packaging & Containers company?
The median EBITDA Margin % among Packaging & Containers companies is 9.60, based on 390 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current EBITDA Margin % of 19.68% is 105.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median EBITDA Margin % is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current EBITDA Margin % is 19.68%, which is 18% below median its own 10-year median of 23.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.98, compared to a current price of ¥17.95 — trading 25.1% below its estimated fair value. The current EBITDA Margin % is 19.68%, which is 18% below median its 10-year median of 23.91 and 105.1% above the Packaging & Containers industry median of 9.60. Shandong Pharmaceutical Glass Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current EBITDA Margin % is 19.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥17.95 is trading 25.1% below its estimated GF Value™ of ¥23.98.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
EBITDA Margin %: 19.68% (18% below median its 10-year median of 23.91)
GF Value™: ¥23.98 vs. price of ¥17.95 (25.1% below fair value)
Industry Position: 105.1% above the Packaging & Containers median (#52 of 390)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Business Description
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
83GF Score
Get the complete analysis for SHSE:600529
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
